No abstract available
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / therapeutic use
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / therapeutic use
-
Bevacizumab
-
Breast Neoplasms / drug therapy
-
Dibenzothiazepines / adverse effects
-
Dibenzothiazepines / therapeutic use
-
Drug Costs
-
Drug Labeling
-
Health Services Accessibility
-
Insurance, Health, Reimbursement
-
Legislation, Drug / trends*
-
Midodrine / adverse effects
-
Midodrine / therapeutic use
-
Off-Label Use / legislation & jurisprudence*
-
Prescription Drugs* / economics
-
Quetiapine Fumarate
-
United States
-
Vasoconstrictor Agents / adverse effects
-
Vasoconstrictor Agents / therapeutic use
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Antipsychotic Agents
-
Dibenzothiazepines
-
Prescription Drugs
-
Vasoconstrictor Agents
-
Quetiapine Fumarate
-
Bevacizumab
-
Midodrine